FGF | Jotup

Fundamental Global Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

Thursday, March 14, 2024

Finance, Banking, Professional Services, Asset Management, Insurance, Growth, Risk, Public, Acquisition, FGF, Nature, Investment, FG, Mergers and acquisitions

Fundamental Global Inc. (Nasdaq: FGF) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced results for the fourth quarter and full year ended December 31, 2023.

Key Points:

Fundamental Global Inc. (Nasdaq: FGF) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced results for the fourth quarter and full year ended December 31, 2023.
The financial results presented in this earnings release reflect the financial results of FG Financial Group, Inc. for the periods ended December 31, 2023, prior to the completion of the Merger, and do not reflect the results of the legacy FG Group Holdings Inc. business.
We look forward to implementing our plans with a focus on shareholder returns.”
Note: The financial results for the fourth quarter and full year 2023 reflect the financial results of FG Financial Group, Inc. and do not include the financial results of FG Group Holdings Inc., which was merged into FG Group LLC, a wholly owned subsidiary of the Company, subsequent to the end of the year.
Fundamental Global Inc.’s 2023 fourth quarter and full year financial results included:
Net reinsurance premiums earned increased to $5.1 million for the three months ended December 31, 2023, from $3.2 million in the fourth quarter of the prior year.

FG Financial Group, Inc. and FG Group Holdings Inc. Complete Merger

Retrieved on:

Thursday, February 29, 2024

CFO, Asset management, Merchant bank, FGF, Cayman, FG

Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial. In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock. Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”). The Company’s common stock and Series A cumulative preferred stock will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively.

Key Points:

Renamed to Fundamental Global Inc.
Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial.
In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock.
Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”).
FG Group Holdings shareholders were resoundingly in favor of this transaction, with 99.9% of the consents returned voting in favor of the plan of merger.

FG Financial Group, Inc. and FG Group Holdings Inc. Complete Merger

Retrieved on:

Thursday, February 29, 2024

CFO, Asset management, Merchant bank, FGF, Cayman, FG

Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial. In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock. Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”). The Company’s common stock and Series A cumulative preferred stock will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively.

Key Points:

Renamed to Fundamental Global Inc.
Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial.
In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock.
Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”).
FG Group Holdings shareholders were resoundingly in favor of this transaction, with 99.9% of the consents returned voting in favor of the plan of merger.

FG Financial Group, Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A

Retrieved on:

Monday, February 5, 2024

Finance, Banking, Professional Services, Asset Management, Insurance, Partnership, Nature, Investment, FGF, Risk, Acquisition, Fundamental, Security (finance)

FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”), for the period commencing on December 15, 2023 and ending on March 14, 2024.

Key Points:

FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”), for the period commencing on December 15, 2023 and ending on March 14, 2024.
The dividend is payable on March 15, 2024, to holders of record on March 1, 2024.
The Preferred Stock is currently listed on the Nasdaq Stock Market and trades under the ticker symbol “FGFPP”.
In particular, discussions and statements regarding the Company’s future business plans and initiatives are forward-looking in nature.

Non-Alcoholic Steatohepatitis Treatment Drug Market In Japan is Expected to Showcase Impressive Growth by 2032 | DelveInsight

Retrieved on:

Wednesday, January 17, 2024

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Non-Alcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, non-alcoholic steatohepatitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into Japan.

Key Points:

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Non-Alcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, non-alcoholic steatohepatitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into Japan.
According to DelveInsight's analysis, the market size for NASH reached USD 200 million in 2022 in Japan and is expected to grow with a significant CAGR by 2032.
DelveInsight's analysis reveals that the overall diagnosed prevalent population of NASH in Japan was reported as 2.5 million in 2022.
Among the forecasted emerging therapies, MGL-3196 (Resmetirom) is expected to capture the highest market in Japan by 2032.

Non-Alcoholic Steatohepatitis Treatment Drug Market In Japan is Expected to Showcase Impressive Growth by 2032 | DelveInsight

Retrieved on:

Wednesday, January 17, 2024

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Non-Alcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, non-alcoholic steatohepatitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into Japan.

Key Points:

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Non-Alcoholic Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, non-alcoholic steatohepatitis emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into Japan.
According to DelveInsight's analysis, the market size for NASH reached USD 200 million in 2022 in Japan and is expected to grow with a significant CAGR by 2032.
DelveInsight's analysis reveals that the overall diagnosed prevalent population of NASH in Japan was reported as 2.5 million in 2022.
Among the forecasted emerging therapies, MGL-3196 (Resmetirom) is expected to capture the highest market in Japan by 2032.

FG GROUP HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of FG Group Holdings Inc. - FGH

Retrieved on:

Tuesday, January 9, 2024

Class Action Lawsuit, Professional Services, Legal, FGF, Sale, KSF, FG, FGH

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

Key Points:

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of FG Group Holdings Inc. (NYSE: FGH) with FG Financial Group, Inc. (NasdaqGM: FGF, FGFPP) pursuant to which FG Group shareholders will receive 1 share of FG Financial for each share of FG Group that they own and will end up owning 72% of the combined company.
KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

FG Financial Group, Inc. and FG Group Holdings Inc. Sign Definitive Plan of Merger to form Fundamental Global Inc.

Retrieved on:

Thursday, January 4, 2024

FGF, Asset management, Beneficial ownership, CFO, JOINT, Form, Merchant bank, PARTIES, FG, FGH, Cayman, Information, Security (finance), BOTH, Communication, Management

Charlotte, NC, Jan. 03, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (NYSE American: FGH) (“FG Group Holdings”) today announced that they have signed a definitive plan of merger to combine the companies in an all-stock transaction. Upon completion of the merger, the combined company will be renamed to Fundamental Global Inc. and the common stock and Series A cumulative preferred stock of the combined company will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively.

Key Points:

Combined Company to Benefit from Anticipated Significant Expense Savings, Improved Scale and Capital Efficiency
Charlotte, NC, Jan. 03, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (NYSE American: FGH) (“FG Group Holdings”) today announced that they have signed a definitive plan of merger to combine the companies in an all-stock transaction.
Additionally, the plan of merger and transaction were approved by the majority stockholder of FG Financial.
FG Group Holdings common stockholders will receive one share of FG Financial common stock for each share of common stock of FG Group Holdings held by such stockholder.
The proposed merger described above will be submitted to FG Group Holdings’ stockholders for their consideration and approval via written consent.

Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tasurgratinib for Biliary Tract Cancer with Fgfr2 Gene Fusion

Retrieved on:

Tuesday, December 19, 2023

TOKYO, Dec 19, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has submitted a marketing authorization application in Japan for its in-house discovered fibroblast growth factor (FGF) receptor (FGFR1, FGFR2, FGFR3) selective tyrosine kinase inhibitor tasurgratinib succinate (generic name, development code: E7090, "tasurgratinib") for biliary tract cancer with FGFR2 gene fusion.

Key Points:

TOKYO, Dec 19, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has submitted a marketing authorization application in Japan for its in-house discovered fibroblast growth factor (FGF) receptor (FGFR1, FGFR2, FGFR3) selective tyrosine kinase inhibitor tasurgratinib succinate (generic name, development code: E7090, "tasurgratinib") for biliary tract cancer with FGFR2 gene fusion.
In Japan, tasurgratinib has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with FGFR2 gene fusion by the Ministry of Health, Labour and Welfare, (MHLW).
This application is based on the results of a multicenter, open-label, single-arm clinical phase II trial (Study 201) in Japan and China conducted by Eisai.
Study 201 enrolled patients with unresectable biliary tract cancer with FGFR2 gene fusion previously treated with gemcitabine-based combination chemotherapy.

Fordham Global Foresight Announces Partnership with Diligent to Help Organisations Navigate an Increasingly Complex Geopolitical Landscape

Retrieved on:

Tuesday, December 5, 2023

Fordham Global Foresight, a preeminent geopolitical advisor to board and C-suite executives, today announced a partnership with Diligent , a leading GRC SaaS company, to offer best in class insight and analysis on the increasingly complex geopolitical landscape.

Key Points:

Fordham Global Foresight, a preeminent geopolitical advisor to board and C-suite executives, today announced a partnership with Diligent , a leading GRC SaaS company, to offer best in class insight and analysis on the increasingly complex geopolitical landscape.
And that's happening against the backdrop of a rapidly shifting global economic and monetary policy landscape.
Previously the first chief global political analyst on Wall Street (Citi) and the first head of global political risk at Eurasia Group, Tina founded Fordham Global Foresight (FGF)in 2022.
Commenting on the partnership, Fordham said: “In a volatile business and investment environment, where globalisation has receded, and geopolitical risks have moved centre stage, systemic risk is heightened.